Joseph H Wender sold $1.6M of Ionis Pharmaceuticals (IONS)

Executed Sep 2 2025, disclosed Sep 4 2025, 2 days later.

Value, as filed

$1.6M

28,000 sh across 3 lots

Executed

Sep 2 2025

the trade date, as filed

Disclosed

Sep 4 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JW Joseph H Wender Director profile →

Joseph H Wender (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $2.3M of IONS (28,000 sh across 2 lots, as filed), executed Dec 1 2025.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joseph H Wender in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $2.3M
28,000 sh across 2 lots
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $2.1M
28,000 sh across 4 lots
Exec Oct 30 2025
Filed Nov 3 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $1.1M
16,800 sh × $65.50
Exec Oct 1 2025
Filed Oct 2 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $1.6M
28,000 sh across 3 lots
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET